Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Universal Testing Experience on a Los Angeles Labor and Delivery Unit
GHDx Entry last modified on: Jan 31, 2024
COVID-19
Dataset Records for COVID-19
Displaying 1051 - 1100 of 1662
Pregnancy Outcomes Among Women With and Without Severe Acute Respiratory Syndrome Coronavirus 2 Infection
GHDx Entry last modified on: Jan 31, 2024
Sero-Prevalence of SARS-CoV-2 Antibodies in High-Risk Populations in Vietnam
GHDx Entry last modified on: Mar 14, 2022
Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic
GHDx Entry last modified on: May 12, 2022
Prevalence of Anti-SARS-CoV-2 Specific Antibodies in Health-Care Workers Compared to General Population during an Early Phase of the Pandemic, Tehran-Iran
GHDx Entry last modified on: Mar 14, 2022
Is Karachi Knocking at Herd Immunity? A Possible Reason for Decline in SARS-CoV-2 Infections. Preprint
GHDx Entry last modified on: Mar 14, 2022
Dynamics of seroconversion of anti-SARS-CoV-2 IgG antibodies in the Czech unvaccinated population: nationwide prospective seroconversion (PROSECO) study. Preprint
GHDx Entry last modified on: May 12, 2022
Long-Term Coronavirus Disease 2019 Complications in Inpatients and Outpatients: A One-Year Follow-up Cohort Study
GHDx Entry last modified on: Apr 10, 2023
Staff SARS-CoV-2 Seroprevalence and Mental Health as Key Factors in University Response to COVID-19 Pandemic
GHDx Entry last modified on: Mar 14, 2022
Prevalence of SARS-CoV-2: An age-stratified, population-based, sero-epidemiological survey in Islamabad, Pakistan. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of COVID-19 in Palestine in 2020. Preprint
Scientific literature:
Epi surveillance
Seroprevalence and risk factors of SARS-CoV-2 infection in an urban informal settlement in Nairobi, Kenya, December 2020 [version 1; peer review: 1 approved with reservations
GHDx Entry last modified on: Jan 31, 2024
Areview of 92 obstetric patients with COVID-19 in the Bronx, New York and their peripartum anaesthetic management
GHDx Entry last modified on: Apr 10, 2023
Coronavirus and birth in Italy: results of a national population-based cohort study
GHDx Entry last modified on: Apr 10, 2023
SARS-CoV-2 infection in pregnancy in Denmark-characteristics and outcomes after confirmed infection in pregnancy: A nationwide, prospective, population-based cohort study
GHDx Entry last modified on: Apr 10, 2023
Maternal and perinatal outcomes in pregnant women with confirmed severe and mild COVID-19 at one large maternity hospital in Chile
GHDx Entry last modified on: Apr 10, 2023
Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands
GHDx Entry last modified on: Apr 10, 2023
Impact of the COVID-19 pandemic on UK endoscopic activity and cancer detection: a National Endoscopy Database Analysis
GHDx Entry last modified on: Apr 10, 2023
Post-acute sequelae of COVID-19 in a non-hospitalized cohort: Results from the Arizona CoVHORT
GHDx Entry last modified on: Mar 22, 2024
Symptom Burden and Immune Dynamics 6 to 18 Months Following Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2): A Case-control Study
GHDx Entry last modified on: Mar 22, 2024
Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: prospective follow-up by phone interviews
GHDx Entry last modified on: Mar 22, 2024
Symptoms of Long-COVID 1-Year after a COVID-19 outbreak among sailors on a French aircraft carrier
GHDx Entry last modified on: Mar 22, 2024
Effect of Different Factors on the Quality of Life and Sequelae of COVID-19 Patients after Discharge
GHDx Entry last modified on: Mar 22, 2024
Development Assistance for Health on COVID-19 Database 2020-2023
GHDx Entry last modified on: May 15, 2025
Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study
GHDx Entry last modified on: Oct 23, 2024
High Community SARS-CoV-2 Antibody Seroprevalence in a Ski Resort Community, Blaine County, Idaho, US. Preliminary Results
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil
GHDx Entry last modified on: Jan 31, 2024
The prevalence of antibodies to SARS-CoV-2 among blood donors in China. Preprint
GHDx Entry last modified on: Mar 14, 2022
Population-based seroprevalence of SARS-CoV-2 is more than halfway through the herd immunity threshold in the State of Maranhao, Brazil. Preprint
GHDx Entry last modified on: May 12, 2022
Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large U.S. Cohort
GHDx Entry last modified on: Jan 31, 2024
Clinical Manifestations and Outcomes of Critically Ill Children and Adolescents with Coronavirus Disease 2019 in New York City
GHDx Entry last modified on: Jan 31, 2024
Association Between Mode of Delivery Among Pregnant Women With COVID-19 and Maternal and Neonatal Outcomes in Spain
GHDx Entry last modified on: Mar 14, 2022
Clinical Implications of SARS-CoV-2 Infection in the Viable Preterm Period
GHDx Entry last modified on: Jan 31, 2024
A pandemic center's experience of managing pregnant women with COVID-19 infection in Turkey: A prospective cohort study
GHDx Entry last modified on: Mar 14, 2022
Universal SARS-Cov-2 Screening in Women Admitted for Delivery in a Large Managed Care Organization
GHDx Entry last modified on: Jan 31, 2024
Outcomes of universal SARS-CoV-2 testing program in pregnant women admitted to hospital and the adjuvant role of lung ultrasound in screening: a prospective cohort study
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 IgG Antibodies in Corsica (France), April and June 2020
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 in Palestine: a cross-sectional seroepidemiological study. Preprint.
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey
GHDx Entry last modified on: May 12, 2022
[Herd Immunity to SARS-CoV-2 among the Population in Saint-Petersburg during the COVID-19 Epidemic]
Популяционный имм унитет к SARS-CoV-2 среди населения Санкт-Петербурга в период эпидемии COVID-19
The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 infection in the craft and manual worker population of Qatar
GHDx Entry last modified on: Jun 17, 2021
[Distribution of SARS-CоV-2 seroprevalence among residents of the Republic of Tatarstan during the COVID-19 epidemic period]
Характеристика серопревалентности к SARS-СoV-2 среди населения Республики Татарстан на фоне COVID-19
SARS-CoV-2: big seroprevalence data from Pakistan-is herd immunity at hand?
GHDx Entry last modified on: May 12, 2022
Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records
GHDx Entry last modified on: Jan 31, 2024
Trends of SARS-CoV-2 antibody prevalence in selected regions across Ghana. Preprint
GHDx Entry last modified on: May 12, 2022
[Seroepidemiological surveillance of SARS-CoV-2 circulation in 41 municipalities in Honduras with no report of active cases, COVID-19, June 16-23, 2020]
Vigilancia seroepidemiológica de la circulación del SARS-CoV-2 en 41 municipios de Honduras sin reporte de casos activos, COVID-19, del 16- 23 junio 2020
Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of IgG Anti-SARS-CoV-2 among Voluntary Blood Donors in Dubai: Demographic and Risk Factors
GHDx Entry last modified on: Mar 14, 2022
Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021
GHDx Entry last modified on: Mar 14, 2022
Subscribe